GlassScriptPhysician profile
Dimple K Kapoor
NPI 1902831134
$3,296.58
in general payments reported to CMS, 2019-2025
17 companies · $890 in 2025
The $890 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $417 · 2020: $14.15 · 2021: $195 · 2022: $601 · 2023: $790 · 2024: $390 · 2025: $890.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,897 · Entertainment: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,896.68 |
| Entertainment | $173.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $850.42 | 2019-2025 | Total30, Precision 1, Dailies Total1 |
| Coopervision INC. | $599.80 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $420.80 | 2022-2025 | Infuse, Miebo, Xiidra |
| Dompe US, INC. | $258.74 | 2022-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $232.29 | 2024-2025 | Xdemvy |
| Optos, INC. | $173.36 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Lkc Technologies, INC. | $117.34 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $114.92 | 2019 | |
| Sight Sciences, INC. | $98.97 | 2022 | |
| Maculogix, INC. | $90.60 | 2019 | |
| Oyster Point Pharma, INC. | $67.68 | 2023 | Tyrvaya |
| Visioneering Technologies, INC. | $64.36 | 2019 | |
| Biotissue Holdings INC. | $61.43 | 2024 | |
| Carl Zeiss Meditec USA, INC. | $55.40 | 2022 | |
| Novartis Pharmaceuticals Corporation | $41.29 | 2021-2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $31.00 | 2021 | |
| Abb Con-Cise Optical Group LLC | $18.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dimple Kapoor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.